[HTML][HTML] Treatment of psoriasis with secukinumab in challenging patient scenarios: a review of the available evidence
JJ Wu, JF Merola, SR Feldman, A Menter… - Dermatology and …, 2020 - Springer
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
[PDF][PDF] Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
JJWJF Merola, SRFA Menter - 2020 - scholar.archive.org
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
JJ Wu, JF Merola, SR Feldman, A Menter… - Dermatology and …, 2020 - go.gale.com
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
JJ Wu, JF Merola, SR Feldman… - Dermatology & …, 2020 - search.ebscohost.com
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
JJ Wu, JF Merola, SR Feldman… - Dermatology …, 2020 - utsouthwestern.elsevierpure.com
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
[HTML][HTML] Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
JJ Wu, JF Merola, SR Feldman, A Menter… - Dermatology and …, 2020 - ncbi.nlm.nih.gov
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
JJ Wu, JF Merola, SR Feldman, A Menter… - Dermatology and …, 2020 - europepmc.org
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
JJ Wu, JF Merola, SR Feldman… - Dermatology and …, 2020 - pubmed.ncbi.nlm.nih.gov
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …
clinical symptoms, including itching, pain, and scaling. PsO is associated with a high …